Literature DB >> 26671891

Fate of new cancer drug is uncertain in Netherlands, as institute deems it too costly.

Pieter van Eijsden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26671891     DOI： 10.1136/bmj.h6778

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Health policy: Affordability of drugs used in oncology health care.

Authors:  Stefan Sleijfer; Jaap Verweij
Journal:  Nat Rev Clin Oncol       Date:  2016-05-10       Impact factor: 66.675

2.  Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.

Authors:  Maarten O Blanken; Geert W Frederix; Elisabeth E Nibbelke; Hendrik Koffijberg; Elisabeth A M Sanders; Maroeska M Rovers; Louis Bont
Journal:  Eur J Pediatr       Date:  2017-11-22       Impact factor: 3.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.